Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment
Gretel Sanabria-Diaz1, Jean-Francois Demonet2, Borja Rodriguez-Herreros3
1LREN, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV), Rue du Bugnon 46, Mont Paisible 16, Lausanne, Vaud 1011, Switzerland; Faculty of Biology and Medicine, University of Lausanne (UNIL), Rue du Bugnon 21, Lausanne CH-1011, Switzerland.
Abstract:
There is evidence that gray matter networks are disrupted in Mild Cognitive Impairment (MCI) and associated with cognitive impairment and faster disease progression. However, it remains unknown how these alterations are related to the presence of Apolipoprotein E isoform E4 (ApoE4), the most prominent genetic risk factor for late-onset Alzheimer's disease (AD). To investigate this topic at the individual level, we explore the impact of ApoE4 and the disease progression on the Single-Subject Gray Matter Networks (SSGMNets) using the graph theory approach. Our data sample comprised 200 MCI patients selected from the ADNI database, classified as non-Converters and Converters (will progress into AD). Each group included 50 ApoE4-positive ('Carriers', ApoE4 + ) and 50 ApoE4-negative ('non-Carriers', ApoE4-). The SSGMNets were estimated from structural MRIs at two-time points: baseline and conversion. We investigated whether altered network topological measures at baseline and their rate of change (RoC) between baseline and conversion time points were associated with ApoE4 and disease progression. We also explored the correlation of SSGMNets attributes with general cognition score (MMSE), memory (ADNI-MEM), and CSF-derived biomarkers of AD (Aβ42, T-tau, and P-tau). Our results showed that ApoE4 and the disease progression modulated the global topological network properties independently but not in their RoC. MCI converters showed a lower clustering index in several regions associated with neurodegeneration in AD. The SSGMNets' topological organization was revealed to be able to predict cognitive and memory measures. The findings presented here suggest that SSGMNets could indeed be used to identify MCI ApoE4 Carriers with a high risk for AD progression.
Insights
Apolipoprotein E4 (ApoE4) and disease progression impact gray matter networks in Mild Cognitive Impairment (MCI). Single-Subject Gray Matter Networks (SSGMNets) can identify MCI patients at high risk for Alzheimer's disease progression.
Area of Science:
- Neuroscience
- Medical Imaging
- Genetics
Background:
- Gray matter network disruptions are linked to Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) progression.
- Apolipoprotein E isoform E4 (ApoE4) is a significant genetic risk factor for late-onset AD, but its specific impact on MCI gray matter networks is unclear.
Purpose of the Study:
- To investigate the individual-level impact of ApoE4 and disease progression on Single-Subject Gray Matter Networks (SSGMNets) in MCI patients.
- To determine if SSGMNets' topological properties and their changes over time correlate with ApoE4 status and conversion to AD.
- To explore the relationship between SSGMNets attributes and cognitive/biomarker measures in MCI.
Main Methods:
- Utilized graph theory to analyze SSGMNets from structural MRIs of 200 MCI patients from the ADNI database.
- Classified patients into converters and non-converters, and further into ApoE4 carriers and non-carriers.
- Assessed network topological measures at baseline and their rate of change (RoC) between baseline and conversion.
Main Results:
- ApoE4 status and disease progression independently modulated global topological network properties, but not their rate of change.
- MCI converters exhibited a reduced clustering index in brain regions affected by AD neurodegeneration.
- SSGMNets' topological organization demonstrated predictive capability for cognitive and memory decline.
Conclusions:
- SSGMNets are sensitive to the influence of ApoE4 and disease progression in MCI.
- Altered network topology in MCI converters is associated with neurodegenerative patterns seen in AD.
- SSGMNets hold potential for identifying MCI ApoE4 carriers at elevated risk for AD progression.
More Related Videos
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
